BIT 3.57% 2.7¢ biotron limited

Ann: Presentation of HIV Data to CROI and New Patents, page-4

  1. 13,013 Posts.
    lightbulb Created with Sketch. 99
    Two things are interesting about this announcement.

    Firstly, we have confirmation that a phase 3 study is now being contemplated and secondly extended toxicology is being done. Neither of these events would be taking place if there were any doubt as to the future potential of 225 in the therapeutic marketplace.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
-0.001(3.57%)
Mkt cap ! $24.36M
Open High Low Value Volume
2.7¢ 2.7¢ 2.7¢ $1.136K 42.07K

Buyers (Bids)

No. Vol. Price($)
4 1950508 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 199924 1
View Market Depth
Last trade - 14.29pm 30/08/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.